12/14/2004 8:49:12 AM ET News Release Index


    SWISS MEDICA EXPANDS INVESTOR AND PRODUCT AWARENESS CAMPAIGN TO U.S. NETWORK RADIO
     
    FOR IMMEDIATE RELEASE

    Stock Symbol: OTC BB: SWME
    December 14, 2004

    SWISS MEDICA EXPANDS INVESTOR AND PRODUCT AWARENESS CAMPAIGN TO U.S. NETWORK RADIO


    Toronto, Canada – Commencing today, Swiss Medica’s Chief Executive Officer, Raghu Kilambi will appear on
    Steve Crowley’s American Scene Radio, which airs on the 200-plus-station Business Radio Network throughout
    the United States and on the Internet. Mr. Kilambi is scheduled for a minimum of 32 network radio guest
    appearances with Mr. Crowley to discuss breaking news developments about Swiss Medica and the Company’s
    US-patented flagship pain relief product, the O24™ Essential Oil Pain Neutralizer.

    ”We are continuing, throughout the United States on a coast-to-coast basis, with the same broadcast medium
    that has brought Swiss Medica’s O24™ superlative brand recognition with the Canadian consumer,” explained
    Raghu Kilambi. “As we move forward with our O24™ product launch across America, we intend to repeat the
    same successful actions that have created sold-out situations for our product in Canada’s leading pharmacy
    chain and wherever O24™ has been offered.”

    Mr. Kilambi may be heard Tuesdays and Thursdays in your local area or online through the webpage link below.
    He will appear this Tuesday at 9:40am Eastern Time and this Thursday at 9:30am Eastern Time. Please check
    www.swissmedica.com, Investor Section, and click on “Calendar” for Mr. Kilambi’s future twice weekly
    appearances.

    www.americansceneradio.com


    About Steve Crowley

    A former CPA Manager with Price Waterhouse & Co, Steve Crowley is the Editor and Host of the daily "American
    Scene" Radio programs which have been airing nationally since June of 1990. Mr. Crowley began his broadcast
    career, in 1981, as WJAR-TV’s financial reporter in Providence, Rhode Island. Over the past twenty years, he
    has been the financial reporter for WPLG-TV in Miami, the host of “Money Talks” for PBS, the Money Editor for
    ABC’s Good Morning America, the award-winning producer of Money/Pro News, Producer and Host of the
    Personal Finance Videos distributed by U.S. News & World Report, and the producer of a home video series for
    The Home Shopping Network.


    About Swiss Medica Inc.

    Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our
    market share through focused distribution strategies in multiple sales channels. Swiss Medica’s mission is to be
    a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please
    visit our websites at www.swissmedica.com and www.024zone.com

    Swiss Medica’s flagship product, the 024™ Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The
    024™ pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits
    by healthcare professionals in the United States, Canada and in Europe. O24 is widely available throughout
    Canada in leading pharmacies and natural food stores. It is available in the United States and elsewhere by
    visiting www.024zone.com, for ordering details and store locators.


    Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the
    United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking
    statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close
    transactions being contemplated, risks related to international sales and potential foreign currency exchange
    fluctuations, continued acceptance of Swiss Medica’s products, increased levels of competition, technological
    changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica’s
    periodic reports filed with the United States Securities and Exchange Commission and other regulatory
    authorities.

    Investor Relations Contact:
    David Jones
    1 866 485 4243
    djones@swissmedica.com